Literature DB >> 33489095

NAFLD in Lean Asians.

Mohammed Eslam1, Fei Chen1, Jacob George1.   

Abstract

Year:  2021        PMID： 33489095      PMCID： PMC7805295          DOI： 10.1002/cld.930

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  14 in total

1.  Liraglutide Decreases Hepatic Inflammation and Injury in Advanced Lean Non-Alcoholic Steatohepatitis.

Authors:  David H Ipsen; Bidda Rolin; Günaj Rakipovski; Gry F Skovsted; Anette Madsen; Stefanie Kolstrup; Anne Marie Schou-Pedersen; Josephine Skat-Rørdam; Jens Lykkesfeldt; Pernille Tveden-Nyborg
Journal:  Basic Clin Pharmacol Toxicol       Date:  2018-07-30       Impact factor: 4.080

2.  Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation.

Authors:  Fei Chen; Saeed Esmaili; Geraint B Rogers; Elisabetta Bugianesi; Salvatore Petta; Giulio Marchesini; Ali Bayoumi; Mayada Metwally; Mahmoud Karimi Azardaryany; Sally Coulter; Jocelyn M Choo; Ramy Younes; Chiara Rosso; Christopher Liddle; Leon A Adams; Antonio Craxì; Jacob George; Mohammed Eslam
Journal:  Hepatology       Date:  2020-01-24       Impact factor: 17.425

Review 3.  Genetics and epigenetics of NAFLD and NASH: Clinical impact.

Authors:  Mohammed Eslam; Luca Valenti; Stefano Romeo
Journal:  J Hepatol       Date:  2017-11-06       Impact factor: 25.083

Review 4.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

5.  Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.

Authors:  Salvatore Petta; Luca Valenti; Antonino Tuttolomondo; Paola Dongiovanni; Rosaria Maria Pipitone; Calogero Cammà; Daniela Cabibi; Vito Di Marco; Anna Ludovica Fracanzani; Sara Badiali; Valerio Nobili; Silvia Fargion; Stefania Grimaudo; Antonio Craxì
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

6.  Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.

Authors:  Alexandra Feldman; Sebastian K Eder; Thomas K Felder; Lyudmyla Kedenko; Bernhard Paulweber; Andreas Stadlmayr; Ursula Huber-Schönauer; David Niederseer; Felix Stickel; Simon Auer; Elisabeth Haschke-Becher; Wolfgang Patsch; Christian Datz; Elmar Aigner
Journal:  Am J Gastroenterol       Date:  2016-08-16       Impact factor: 10.864

7.  Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.

Authors:  Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Ruth Suk-Mei Chan; Sally She-Ting Shu; Bernice Ho-Ki Cheung; Liz Sin Li; Angel Mei-Ling Chim; Carmen Ka-Man Chan; Julie Ka-Yu Leung; Winnie Chiu-Wing Chu; Jean Woo; Henry Lik-Yuen Chan
Journal:  J Hepatol       Date:  2018-08-22       Impact factor: 25.083

8.  Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.

Authors:  Nathan A Johnson; Toos Sachinwalla; David W Walton; Kate Smith; Ashley Armstrong; Martin W Thompson; Jacob George
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

9.  Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts.

Authors:  Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa M Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel A Muñoz; José V Sorlí; J Alfredo Martínez; Montserrat Fitó; Alfredo Gea; Miguel A Hernán; Miguel A Martínez-González
Journal:  N Engl J Med       Date:  2018-06-13       Impact factor: 91.245

10.  Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study.

Authors:  Hannes Hagström; Patrik Nasr; Mattias Ekstedt; Ulf Hammar; Per Stål; Rolf Hultcrantz; Stergios Kechagias
Journal:  Hepatol Commun       Date:  2017-11-30
View more
  5 in total

1.  Clinical Differences and Non-Alcoholic Fatty Liver Disease-Related Factors of Lean and Non-Lean Patients with Metabolic Syndrome.

Authors:  Punyisa Boonchai; Chayanis Kositamongkol; Suchanart Jitrukthai; Sukumal Phothirat; Euarat Mepramoon; Pongpol Nimitpunya; Weerachai Srivanichakorn; Thanet Chaisathaphol; Chaiwat Washirasaksiri; Chonticha Auesomwang; Tullaya Sitasuwan; Rungsima Tinmanee; Naruemit Sayabovorn; Phunchai Charatcharoenwitthaya; Pochamana Phisalprapa
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

Review 2.  Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.

Authors:  Eda Kaya; Yusuf Yilmaz
Journal:  J Clin Transl Hepatol       Date:  2021-10-19

Review 3.  Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity.

Authors:  Partha Pal; Rajan Palui; Sayantan Ray
Journal:  World J Hepatol       Date:  2021-11-27

4.  The egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Yasser Fouad; Gamal Esmat; Reda Elwakil; Serag Zakaria; Ayman Yosry; Imam Waked; Maissa El-Razky; Wahid Doss; Magdy El-Serafy; Ebraheem Mostafa; Mahmood Anees; Mohamed A Sakr; Nadia AbdelAty; Ashraf Omar; Samy Zaki; Amgad Al-Zahaby; Hamdy Mahfouz; Maysaa Abdalla; Mahmoud Albendary; Abdel-Khalek Hamed; Ahmed Gomaa; Adel Hasan; Sherif Abdel-Baky; Medhat El Sahhar; Gamal Shiha; Dina Attia; Ebada Saeed; Enas Kamal; Shamardan Bazeed; Mai Mehrez; Shereen Abdelaleem; Yasmine Gaber; Mohammed Abdallah; Asmaa Salama; Doaa A Tawab; Shaymaa Nafady
Journal:  Saudi J Gastroenterol       Date:  2022 Jan-Feb       Impact factor: 2.485

5.  Clinical Factors Associated with Non-Obese Nonalcoholic Fatty Liver Disease Detected among US Adults in the NHANES 2017-2018.

Authors:  Zayd Adnan Razouki; Xiaotao Zhang; Jessica P Hwang; Natalia I Heredia
Journal:  J Clin Med       Date:  2022-07-22       Impact factor: 4.964
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.